3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Pancreatic Neoplasms
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Mantle-Cell
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Breast Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Lymphoma, Extranodal NK-T-Cell
3
Lymphoma
3
Leukemia, Myeloid, Acute
3
Hodgkin Disease
3
Glioblastoma
3
Congenital Abnormalities
3
Carcinoma, Non-Small-Cell Lung
3
Burkitt Lymphoma
3
Waldenstrom Macroglobulinemia
2
Squamous Cell Carcinoma of Head and Neck
2
Sezary Syndrome
2
Rectal Neoplasms
2
Mycosis Fungoides
2
Multiple Myeloma
2
Lymphoma, Large-Cell, Anaplastic
2
Leukemia, Prolymphocytic
2
Leukemia
2
Interventions
Radiotherapy
5
Temozolomide
4
Radiation
3
Irinotecan
3
Bevacizumab
3
ribociclib
2
abemaciclib
2
Vorinostat
2
Mebendazole
2
Everolimus
2
Dasatinib
2
vandetanib
1
temsirolimus
1
sargramostim
1
reolysin
1
pembrolizumab
1
ovex
1
nimotuzumab
1
irinotecan sucrosofate
1
dinutuximab
1
crenolanib
1
adavosertib
1
Vincristine
1
Valproic Acid
1
Sirolimus
1
Re-Irradiation
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiation Dose Hypofractionation
1
Piperazine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Diffuse Intrinsic Pontine Glioma
×
Pharmacogenomic Testing
×
Clear all
NCT01165333
2026-03-16
CILENT
Centre Oscar Lambret
Phase 1
Completed
32 enrolled